Large B-Cell Lymphoma (LBCL)
11 clinical trials · Condition
◉ Watch Large B-Cell Lymphoma (LBCL)
| Record | Firm | Date |
|---|---|---|
| CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma (NCT07461831) | Beijing Tongren Hospital | 2022-02-01 |
| Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma (NCT07524816) | N.N. Alexandrov National Cancer Centre | 2021-06-01 |
| CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma (NCT04661020) | Zhejiang University | 2020-12-03 |
Track Large B-Cell Lymphoma (LBCL) automatically
Every clearance here is in the API, with alerts when new ones post.